Literature DB >> 35960429

Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.

Gabriel Ștefan1,2, Adrian Zugravu3,4, Simona Stancu3,4.   

Abstract

Entities:  

Keywords:  Cyclic steroid-oral cyclophosphamide; High risk primary PLA2R positive membranous nephropathy; Intravenous cyclophosphamide

Year:  2022        PMID： 35960429     DOI： 10.1007/s40620-022-01426-6

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   4.393


× No keyword cloud information.
  3 in total

1.  Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis.

Authors:  Andrea Angeletti; Maurizio Bruschi; Gabriella Moroni; Renato Alberto Sinico; Franco Franceschini; Micaela Fredi; Augusto Vaglio; Lorenzo Cavagna; Andrea Petretto; Federico Pratesi; Paola Migliorini; Francesco Locatelli; Giulia Pazzola; Giampaola Pesce; Marcello Bagnasco; Angelo Manfredi; Giuseppe A Ramirez; Pasquale Esposito; Giuseppe Murdaca; Simone Negrini; Leda Cipriani; Barbara Trezzi; Giacomo Emmi; Ilaria Cavazzana; Valentina Binda; Matteo d'Alessandro; Paride Fenaroli; Isabella Pisani; Giacomo Garibotto; Carlomaurizio Montecucco; Domenico Santoro; Francesco Scolari; Stefano Volpi; Marta Mosca; Angela Tincani; Giovanni Candiano; Marco Prunotto; Enrico Verrina; Angelo Ravelli; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2021-10-01       Impact factor: 10.121

2.  Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.

Authors:  Gabriel Stefan; Simona Stancu; Adrian Zugravu; Otilia Popa; Dalia Zubidat; Nicoleta Petre; Gabriel Mircescu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

3.  Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy.

Authors:  Vinod Mathrani; Abdulfattah Alejmi; Siân Griffin; Gareth Roberts
Journal:  Clin Kidney J       Date:  2017-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.